These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 35218967)

  • 1. Cellular membrane-based vesicles displaying a reconstructed B cell maturation antigen for multiple myeloma therapy by dual targeting APRIL and BAFF.
    He C; Zhang M; Liu L; Han Y; Xu Z; Xiong Y; Yan F; Su D; Chen H; Zheng Y; Cheng F
    Acta Biomater; 2022 Apr; 143():406-417. PubMed ID: 35218967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. APRIL and BCMA promote human multiple myeloma growth and immunosuppression in the bone marrow microenvironment.
    Tai YT; Acharya C; An G; Moschetta M; Zhong MY; Feng X; Cea M; Cagnetta A; Wen K; van Eenennaam H; van Elsas A; Qiu L; Richardson P; Munshi N; Anderson KC
    Blood; 2016 Jun; 127(25):3225-36. PubMed ID: 27127303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B-cell maturation antigen (BCMA) activation exerts specific proinflammatory effects in normal human keratinocytes and is preferentially expressed in inflammatory skin pathologies.
    Alexaki VI; Pelekanou V; Notas G; Venihaki M; Kampa M; Dessirier V; Sabour-Alaoui S; Stathopoulos EN; Tsapis A; Castanas E
    Endocrinology; 2012 Feb; 153(2):739-49. PubMed ID: 22166983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble B-Cell Maturation Antigen Mediates Tumor-Induced Immune Deficiency in Multiple Myeloma.
    Sanchez E; Gillespie A; Tang G; Ferros M; Harutyunyan NM; Vardanyan S; Gottlieb J; Li M; Wang CS; Chen H; Berenson JR
    Clin Cancer Res; 2016 Jul; 22(13):3383-97. PubMed ID: 26960399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stoichiometry of Heteromeric BAFF and APRIL Cytokines Dictates Their Receptor Binding and Signaling Properties.
    Schuepbach-Mallepell S; Das D; Willen L; Vigolo M; Tardivel A; Lebon L; Kowalczyk-Quintas C; Nys J; Smulski C; Zheng TS; Maskos K; Lammens A; Jiang X; Hess H; Tan SL; Schneider P
    J Biol Chem; 2015 Jun; 290(26):16330-42. PubMed ID: 25953898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hodgkin lymphoma cells express TACI and BCMA receptors and generate survival and proliferation signals in response to BAFF and APRIL.
    Chiu A; Xu W; He B; Dillon SR; Gross JA; Sievers E; Qiao X; Santini P; Hyjek E; Lee JW; Cesarman E; Chadburn A; Knowles DM; Cerutti A
    Blood; 2007 Jan; 109(2):729-39. PubMed ID: 16960154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineering an APRIL-specific B cell maturation antigen.
    Patel DR; Wallweber HJ; Yin J; Shriver SK; Marsters SA; Gordon NC; Starovasnik MA; Kelley RF
    J Biol Chem; 2004 Apr; 279(16):16727-35. PubMed ID: 14764606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study on the Mechanism of Selective Interaction of BR3 and BCMA with BAFF and APRIL.
    Li L; Jiang Y; Su L; Feng D; Wei J; Sun J
    Protein Pept Lett; 2020; 27(11):1114-1123. PubMed ID: 32282294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BAFF and APRIL induce inflammatory activation of THP-1 cells through interaction with their conventional receptors and activation of MAPK and NF-κB.
    Lee SM; Kim EJ; Suk K; Lee WH
    Inflamm Res; 2011 Sep; 60(9):807-15. PubMed ID: 21505913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant expression of functional BAFF-system receptors by malignant B-cell precursors impacts leukemia cell survival.
    Maia S; Pelletier M; Ding J; Hsu YM; Sallan SE; Rao SP; Nadler LM; Cardoso AA
    PLoS One; 2011; 6(6):e20787. PubMed ID: 21687682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BAFF and APRIL support chronic lymphocytic leukemia B-cell survival through activation of the canonical NF-kappaB pathway.
    Endo T; Nishio M; Enzler T; Cottam HB; Fukuda T; James DF; Karin M; Kipps TJ
    Blood; 2007 Jan; 109(2):703-10. PubMed ID: 16973958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BAFF and APRIL protect myeloma cells from apoptosis induced by interleukin 6 deprivation and dexamethasone.
    Moreaux J; Legouffe E; Jourdan E; Quittet P; Rème T; Lugagne C; Moine P; Rossi JF; Klein B; Tarte K
    Blood; 2004 Apr; 103(8):3148-57. PubMed ID: 15070697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphoma B cells evade apoptosis through the TNF family members BAFF/BLyS and APRIL.
    He B; Chadburn A; Jou E; Schattner EJ; Knowles DM; Cerutti A
    J Immunol; 2004 Mar; 172(5):3268-79. PubMed ID: 14978135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selectivity of BAFF/BLyS and APRIL for binding to the TNF family receptors BAFFR/BR3 and BCMA.
    Day ES; Cachero TG; Qian F; Sun Y; Wen D; Pelletier M; Hsu YM; Whitty A
    Biochemistry; 2005 Feb; 44(6):1919-31. PubMed ID: 15697217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. APRIL binding to BCMA activates a JNK2-FOXO3-GADD45 pathway and induces a G2/M cell growth arrest in liver cells.
    Notas G; Alexaki VI; Kampa M; Pelekanou V; Charalampopoulos I; Sabour-Alaoui S; Pediaditakis I; Dessirier V; Gravanis A; Stathopoulos EN; Tsapis A; Castanas E
    J Immunol; 2012 Nov; 189(10):4748-58. PubMed ID: 23071284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. APRIL and BAFF proteins increase proliferation of human adipose-derived stem cells through activation of Erk1/2 MAP kinase.
    Zonca M; Mancheño-Corvo P; DelaRosa O; Mañes S; Büscher D; Lombardo E; Planelles L
    Tissue Eng Part A; 2012 Apr; 18(7-8):852-9. PubMed ID: 22059379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective Binding BAFF/APRIL by the In and Outside Conservative Region of BCMA.
    Zheng C; Zhang X; Zhao Z; Hao X; Wei J; Sun J
    Protein Pept Lett; 2017; 24(6):489-494. PubMed ID: 28260502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding of B-cell maturation antigen to B-cell activating factor induces survival of multiple myeloma cells by activating Akt and JNK signaling pathways.
    Shen X; Guo Y; Qi J; Shi W; Wu X; Ju S
    Cell Biochem Funct; 2016 Mar; 34(2):104-10. PubMed ID: 26914861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of B-cell-activating factor in adhesion and growth of human multiple myeloma cells in the bone marrow microenvironment.
    Tai YT; Li XF; Breitkreutz I; Song W; Neri P; Catley L; Podar K; Hideshima T; Chauhan D; Raje N; Schlossman R; Richardson P; Munshi NC; Anderson KC
    Cancer Res; 2006 Jul; 66(13):6675-82. PubMed ID: 16818641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-BCMA-engineered exosomes for bortezomib-targeted delivery in multiple myeloma.
    Yuan S; Li Q; He C; Bing M; Zhang X; Xu H; Wang Z; Zhao M; Zhang Y; Chai Y; Li B; Zhuang W
    Blood Adv; 2024 Sep; 8(18):4886-4899. PubMed ID: 38875465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.